
Drug companies to pay $125 million in AWP settlement
Eleven drug companies settled litigation that charged they knowingly inflated average wholesale price for drugs in the Medicare Part B program.
Eleven pharmaceutical companies have agreed to pay $125 million to settle a case in which they allegedly inflated the average wholesale prices (AWP) on certain prescription drugs in the Medicare Part B program. In separate
To see more Daily News articles,
To go to the Drug Topics homepage,
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.


























































































































































